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Antimicrobial peptide cWFW 
kills by combining lipid phase 
separation with autolysis
Kathi Scheinpflug1, Michaela Wenzel2,†, Oxana Krylova1, Julia E. Bandow2, Margitta Dathe1 & 
Henrik Strahl3
The synthetic cyclic hexapeptide cWFW (cyclo(RRRWFW)) has a rapid bactericidal activity against 
both Gram-positive and Gram-negative bacteria. Its detailed mode of action has, however, remained 
elusive. In contrast to most antimicrobial peptides, cWFW neither permeabilizes the membrane nor 
translocates to the cytoplasm. Using a combination of proteome analysis, fluorescence microscopy, 
and membrane analysis we show that cWFW instead triggers a rapid reduction of membrane fluidity 
both in live Bacillus subtilis cells and in model membranes. This immediate activity is accompanied by 
formation of distinct membrane domains which differ in local membrane fluidity, and which severely 
disrupts membrane protein organisation by segregating peripheral and integral proteins into domains 
of different rigidity. These major membrane disturbances cause specific inhibition of cell wall synthesis, 
and trigger autolysis. This novel antibacterial mode of action holds a low risk to induce bacterial 
resistance, and provides valuable information for the design of new synthetic antimicrobial peptides.
Antimicrobial peptides (AMPs) have been in the focus of research attention as a promising alternative for con-
ventional antibiotics1. The subclass of arginine- and tryptophan-rich peptides, with cationic charge and hydro-
phobic residues, provides the ideal structural prerequisite for interaction with the negatively charged bacterial 
membranes2. To elucidate optimal structure-activity properties we screened a library of small synthetic peptides 
derived from the active motif of human antimicrobial peptide lactoferricin3. This analysis identified the cyclic 
hexapeptide cWFW (cyclo-RRRWFW) as the most potent candidate. It turned out that this peptide is active 
against both Gram-positive and Gram-negative bacteria at low micromolar concentrations, and displays strong 
selectivity, i.e. it is not toxic towards human cells4. The antibacterial activity of cWFW is further characterised by 
a rapid killing kinetic and a bactericidal effect at the minimal inhibitory concentration5. To develop cWFW as a 
novel, highly efficient antibiotic lead compound, we now need a precise knowledge of its mechanism of action.
Earlier studies have suggested that the cytoplasmic membrane is the primary peptide target but it is unknown 
how this interaction kills bacteria5,6. In contrast to most AMPs, however, cWFW does not permeabilize the cell 
membrane to large molecules5,6. As first postulated by Epand and Epand7, short cationic AMPs might, as an 
alternative mechanism, induce clustering of anionic lipids within the bacterial membrane due to electrostatic 
interactions8. This effect, which is highly dependent on the phospholipid composition and requires the presence 
of both negatively charged and zwitterionic lipid species, could later be confirmed for small cyclic hexapeptides 
including cWFW in vitro9,10. Whether this clustering indeed takes place in vivo, and whether it contributes to the 
antibacterial activity of cWFW has so far remained unanswered.
In this manuscript, we now present a comprehensive mode of action analysis demonstrating that cWFW, 
uniquely for a cationic antimicrobial peptide, neither depolarises the membrane nor otherwise adversely affects 
the energy state of the cell. Instead, cWFW strongly reduces membrane fluidity both in vivo and in vitro, and trig-
gers a large scale phase-separation of the cytoplasmic membrane. In contrast to the previously suggested models, 
the cWFW-triggered lipid phase separation is independent of both the negatively charged phospholipid cardi-
olipin and the zwitterionic phospholipid phosphatidyl ethanolamine, and thus represents a novel activity for a 
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membrane-targeting peptide. Moreover, the in vivo domain formation causes a striking segregation of peripheral 
and integral membrane proteins into separate membrane areas. This strong disturbance of membrane organisa-
tion inhibits cell wall synthesis and triggers autolysis. We consider these effects as a novel mechanism of action for 
antimicrobial peptides, and discuss the implication on antimicrobial resistance.
Results
Analysis of the cWFW-triggered cellular stress response. To identify which cellular processes are 
disturbed by cWFW, we performed proteomic profiling of the Gram-positive model organism B. subtilis (Fig. 1). 
This technique combines radioactive pulse-labeling of newly synthesised proteins with two-dimensional SDS 
PAGE, thus providing insight into the acute antibiotic stress response11. The proteomic stress response profile, 
consisting of marker proteins upregulated after antibiotic addition, is highly specific for the imposed stress and 
thus indicative of the antibiotic’s mechanism of action11.
In agreement with the cytoplasmic membrane as the likely cellular target6, cWFW elicited a typical cell enve-
lope stress response characterised by upregulation of proteins controlled by the extracytoplasmic function (ECF) 
sigma factors SigM, SigW and SigX (Table 1). In addition, marker proteins indicative of membrane damage 
(phage shock protein PspA and NAD synthase NadE) and impairment of membrane-bound steps of cell wall syn-
thesis (PspA homologue LiaH and the Sigma M-controlled protein YpuA) were upregulated. Further upregulated 
proteins point towards remodeling of the cell wall (RacX, DltA) and membrane (YjdA, YoxD, IspH), accompanied 
by changes in central carbon metabolism (TpiA, FbaA, CitZ) and activation of the SigB-dependent general stress 
response.
When comparing the cWFW-triggered stress response to a proteome response library12 we found the highest 
overlap with the antimicrobial peptide MP196, but also a striking similarity with gramicidin S and valinomy-
cin (Supplementary Table 1). The linear hexapeptide MP196 de-energises the cell by inhibition of respiration13 
whereas the cyclodecapeptide gramicidin S dissipates membrane potential via transient ion conductance events14. 
Membrane depolarisation caused by the ion carrier valinomycin is a direct result of specific potassium trans-
port15. Similarities in the proteomic response elicited by compounds which directly interfere with cell wall syn-
thesis such as vancomycin and mersacidin, or other specific ionophores such as gramicidin A or ionomycin were 
comparably low (Supplementary Table 1).
Together, these results argue against a specific proteinaceous target for cWFW. Instead, cWFW is more likely 
to target the cytoplasmic membrane and to cause extensive interference with membrane-associated processes 
including energy metabolism, cell wall synthesis, and membrane homeostasis. The following paragraphs focus on 
how cWFW affects these different aspects of B. subtilis physiology.
Membrane permeability and cell energy state. Earlier investigations have suggested that cWFW does 
not permeabilize the cytoplasmic membrane of E. coli, or form pores in model membranes5,6. However, the induc-
tion of the general SigB-dependent stress response and the similarity of the proteomic response triggered by 
MP196 and gramicidin S suggests that cWFW might nevertheless cause energy starvation linked to membrane 
depolarisation in B. subtilis.
To test this possibility, we first analysed the cellular membrane potential with the voltage-sensitive dye 
DiSC3(5)16. As shown in Fig. 2a, the fluorescence intensity of DiSC3(5)-stained cell suspension was slightly 
Figure 1. Cytosolic proteome response profile of B. subtilis to cWFW. Autoradiographs of antibiotic-
treated cells (red) were overlaid with those of untreated controls (green). Upregulated proteins in response 
to cWFW treatment (8 μ M) appear red, down-regulated proteins green. Proteins synthesised at equal rates 
appear yellow. Proteins upregulated more than 2-fold in three biological replicates were defined as marker 
proteins and identified by mass spectrometry. Unidentified marker proteins are indicated by circles. See 
supplementary Figure 1a for the growth inhibition of B. subtilis observed in BMM with different cWFW 
concentrations. Strain used: B. subtilis 168/DSM 402.
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protein
induction 
factor known or predicted function regulon functional category
YceC* 9.9 similar to tellurium resistance protein SigW, SigM, SigB, SigX
cell envelope general 
stress
FosB 8.3 bacillithiol-S-transferase, fosfomycin resistance SigW cell envelope
YfhM 5.8 similar to epoxide hydrolase, general stress protein SigW, SigB cell envelope general stress
YthP 5.9 similar to ABC transporter (ATP-binding protein) SigW cell envelope
YvlB 9.0 unknown SigW cell envelope
GtaB 3.2 UTP-glucose-1-phosphate uridylyltransferase, general stress protein SigB
cell envelope general 
stress
LiaH# 16.6 similar to phage shock protein LiaRS cell wall
RacX 12.0 amino acid racemase SigW cell wall
YpuA# 4.0 unknown SigM cell wall
DltA 4.2 D-alanyl-D-alanine carrier protein ligase, antimicrobial peptide resistance
SigD, SigM, 
SigX, Spo0A cell wall
PspA° 9.5 phage shock protein A homologue SigW, AbrV membrane
AcsA 3.7 acetyl-CoA synthetase CcpA, CodY membrane
YjdA 3.4 similar to 3-oxoacyl-acyl-carrier protein reductase unknown membrane
YoxD 7.1 similar to 3-oxoacyl-acyl-carrier protein reductase unknown membrane
IspH 19.0 4-hydroxy-3-methylbut-2-enyl diphosphate reductase, isoprene biosynthesis unknown membrane
NadE° 11.0 NAD synthase SigB energy
NfrA 5.7 FMN-containing NADPH-linked nitro/flavin reductase
SigD, Spo0A, 
Spx energy
YwrO 4.3 similar to NAD(P)H oxidoreductase unknown energy
CitZ 3.5 citrate synthase CcpA, CcpC energy
YqkF 7.7 similar to oxidoreductase unknown energy
TpiA 5.8 triose phosphate isomerase, glycolytic/gluconeogenic enzyme CggR energy
YwjI 6.4 class II fructose-1,6-bisphosphatase, gluconeogenesis unknown energy
FbaA 2.9 fructose 1,6-bisphosphate aldolase, glycolytic/gluconeogenic enzyme unknown energy
PepF 3.6 oligoendopeptidase unknown phosphorelay
PurH 3.4 phosphoribosylaminoimidazole carboxamide formyltransferase PurR, G-box nucleotide biosynthesis
GsiB 8.4 general stress protein SigB general stress
YvyD 6.2 general stress protein, required for ribosome dimerization in stationary phase SigB, SigH general stress
YdaG 5.6 general stress protein SigB general stress
OhrB 4.4 general stress protein SigB general stress
Dps 5.2 general stress protein, iron storage protein SigB general stress iron metabolism
ClpP 4.8 ATP-dependent Clp protease proteolytic subunit (class III heat-shock protein) SigB, CtsR general stress heat shock
ClpC 5.4 ATPase subunit of the ATP-dependent ClpC-ClpP protease
SigB, SigF, 
CtsR general stress heat shock
GroEL 3.9 chaperonin HrcA chaperone heat shock
SodA 3.0 superoxide dismutase SigB oxidative stress
Tpx 4.1 thiol peroxidase Spx oxidative stress
YqiW 2.4 unknown, disulfide isomerase family unknown oxidative stress
YdbD 19.4 similar to manganese-containing catalase SigB oxidative stress
LuxS 3.4 S-ribosylhomocysteine lyase, swarming, biofilm formation, methionine salvage unknown motility, biofilm
MinD 3.1 cell division site placement SigH, SigM cell division envelope stress
SpoVG 2.4 negative effector of asymmetric septation SigH. SinR, AbrB cell division sporulation
YkaA 4.6 unknown Spo0A sporulation
SalA 3.5 negative regulator of scoC expression, derepression of subtilisin ScoC, SalA
gene regulation 
proteolysis
Table 1.  Marker proteins upregulated upon cWFW treatment. *Specific marker for cell envelope stress, 
°specific marker for membrane stress, #specific marker for inhibition of membrane-bound cell wall biosynthesis 
steps43.
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increased at growth-inhibitory concentrations (8 μ M) and above (Supplementary Figure 1). This indicates a 
detectable degree of membrane depolarisation caused by cWFW but the observed effect was very low compared 
to that of the positive control KLA-1, which is a pore-forming peptide fully dissipating the membrane potential17. 
In addition, cWFW-induced depolarisation was only transient at growth-inhibitory concentrations (8–12 μ M) 
and the membrane potential was restored almost to control levels within 10 min (Fig. 2a). In agreement with these 
measurements, a minor reduction of cellular ATP levels was observed only at elevated concentrations of cWFW 
(Fig. 2b).
To verify these findings with independent assays, we next analysed cWFW-triggered changes in cellular ion 
content, and performed conductivity measurements on bacterial model membranes. Consistent with the lack of 
significant membrane depolarisation, no leakage of cellular ions was observed in vivo (Fig. 2c). In contrast, an 
accumulation of K+ upon addition of cWFW was observed. At last, only a minor ion flux was induced in model 
bilayers compared to the pore-forming peptide KLA-1 (Fig. 2d).
Together, these analyses demonstrate that cWFW neither permeabilizes the cytoplasmic membrane nor acts 
as a carrier for the analysed ion species. cWFW thus exhibits a mode of action which clearly sets it apart from typ-
ical membrane targeting antimicrobial peptides which either form ion-conducting pores, or otherwise interfere 
with the membrane diffusion barrier function and cell energy state.
cWFW interferes with membrane homeostasis by reducing membrane fluidity. Although the 
membrane barrier function is not significantly impaired, there is convincing evidence that cWFW can directly 
influence lipid bilayers upon binding10,18. Therefore, we focussed on analysing two plausible effects through which 
cWFW could interfere with the bacterial cytoplasmic membrane: (i) disturbance of membrane homeostasis and 
(ii) lipid domain formation.
Biological membranes are maintained in an appropriate state of fluidity which optimally promotes the 
activity and diffusion of membrane proteins while maintaining sufficiently low passive permeability19. 
Antimicrobial peptide-triggered changes in fluidity have been observed in model membranes systems 
in vitro20,21, and very recently for the lipopeptide daptomycin in vivo22. To test whether cWFW can disturb the 
fluidity of the cytoplasmic membrane, we used the fluidity-sensitive fluorescent dye laurdan. Indeed, a clear 
concentration-dependent increase in laurdan generalised polarisation (GP) was observed upon incubation of 
B. subtilis with cWFW (Fig. 3a). This indicates a substantial reduction of membrane fluidity. Crucially, minor 
changes were already observed at concentrations which are growth-limiting but not sufficient to fully abolish 
growth (Supplementary Figure 1).
B. subtilis can adjust the membrane fatty acid composition and thus membrane fluidity upon stress23. 
Unsurprisingly, the cWFW-dependent membrane disturbances also trigger an adaptive response on the level of 
membrane fatty acid composition. (Supplementary Figure 2). To distinguish between a direct activity of cWFW 
and a potential cellular adaptation process, we measured time-resolved laurdan GP upon addition of cWFW 
(Fig. 3b). It turned out that the reduction of membrane fluidity occurs very rapidly upon addition and reaches a 
steady state within only 2 min, thus suggesting that observed membrane rigidification is a direct consequence of 
cWFW-membrane interaction.
To verify that the reduction of membrane fluidity is indeed direct activity of cWFW and to gain insight into 
a possible lipid-specificity of this phenomenon, we analysed the ability of cWFW to reduce membrane fluidity 
in an in vitro model system using large unilamellar vesicles (LUVs) composed of bacterial membrane lipids. A 
distinct concentration-dependent reduction of membrane fluidity was observed with liposomes formed from E. 
coli polar lipid extracts (Fig. 3c, Supplementary Figure 3b). This confirms that membrane rigidification is indeed 
a direct consequence of cWFW intercalation into the lipid bilayer. We next analysed whether the ability of cWFW 
to reduce membrane fluidity requires a complex fatty acid composition found in biological membranes, or relies 
on the presence of specific phospholipid head group species. For this aim, we repeated the experiments with 
liposomes composed of binary mixtures of POPE/POPG and POPE/CL, respectively. A clear reduction of mem-
brane fluidity was observed in both cases, indicating that the peptide activity is independent of the investigated 
composition of POPE-based lipid mixtures which mimic bacterial membranes (Fig. 3d and e). However, we did 
observe a slightly stronger reduction of fluidity in liposomes containing cardiolipin, a result consistent with the 
preferred partitioning of cWFW into cardiolipin-containing POPE membranes6.
In summary, the intercalation of cWFW into lipid bilayers results in a rapid reduction of membrane fluidity 
both on the cellular level and in model lipid bilayers. For the investigated bilayer systems, the ability to reduce 
membrane fluidity is independent of specific fatty acids or lipid head groups.
cWFW triggers a novel type of lipid domain formation in vivo. The reduction of membrane fluidity 
upon addition of cWFW can either be caused by a uniform effect on the cytoplasmic membrane or by forma-
tion of specific domains which differ in fluidity. To address this question, we analysed cells stained with the 
fluidity-sensitive uncharged membrane dye nile red24,25. Upon addition of cWFW, the fluorescent membrane 
stain initially remained homogeneous indicating that the reduction of membrane fluidity extends to the entire 
cytoplasmic membrane (Fig. 4a). However, after a prolonged incubation, a striking separation of the membrane 
into two distinct areas was observed (Fig. 4a). This lipid domain formation was also reflected in the distribution 
of fluorescently labelled cWFW (Fig. 4b and c).
We have previously shown that cWFW treatment results in lipid demixing of PE/PG bilayers in vitro9,10. 
Moreover, PE and cardiolipin have been reported to form lipid domains in B. subtilis membranes26. The observed 
domains could therefore indicate aberrant clustering of these specific lipid species. To test this hypothesis, we 
repeated nile red staining with cells incapable of producing the zwitterionic PE or the negatively charged cardi-
olipin, respectively. To our surprise, the absence of neither of these major phospholipid species had an influence 
www.nature.com/scientificreports/
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on the domain formation (Fig. 4d) or on the MIC of cWFW (Supplementary Table 4). Hence, the observed in vivo 
phase separation is not determined by clustering of PE or CL, or by the demixing of PE and negatively charged 
phospholipids. Instead, a microscopic analysis of laurdan GP revealed a clear difference in the local fluidity of 
the observed domains (Fig. 5e). The cWFW-triggered lipid domain formation thus exhibits characteristics rem-
iniscent of membrane phase separation driven by changes in the physical state of the membrane, rather than by 
enrichment of specific lipid species.
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Figure 2. Impact of cWFW on cell energy state and membrane permeability. (a) Membrane potential 
levels of B. subtilis upon addition of different cWFW concentrations were measured using fluorescent voltage-
sensitive dye DiSC3(5). For positive control, cells were depolarised by addition of the helical pore-forming 
antimicrobial peptide KLA-1 (40 μ M). The time points of DiSC3(5) and peptide additions are highlighted with 
dashed lines. See supplementary Figure 1b for growth inhibition at identical cWFW-concentrations and cell 
densities. The graph depicts a representative measurement of three independent replicates. (b) ATP levels in B. 
subtilis after 20 min incubation with different cWFW concentrations were measured using a Luciferase-based 
luminescence assay. For positive control, cells were incubated with the proton ionophore CCCP (100 μ M). Cell 
densities are comparable to the data shown in panel A and supplementary Figure 1b. The diagram depicts the 
average and standard deviation values of three independent replicates. No significant changes (p ≥ 0.05) were 
observed for samples treated with 4, 8, and 12 μ M cWFW. (c) Changes in relative ion content of B. subtilis upon 
15 min incubation with 8 μ M cWFW were determined using inductively-coupled plasma optical emission 
spectroscopy (ICP-OES). Phosphorus, mainly prevalent in DNA-bound form, served as internal control for cell 
mass. The diagram depicts the average and standard deviation values of three independent measurements. No 
significant changes (p ≥ 0.05) were observed ions other than K+. See supplementary Figure S1a for the growth 
inhibition of B. subtilis observed in BMM with different cWFW concentrations. (d) Conductivity measurements 
on planar lipid membranes formed of E. coli lipid extract upon addition of 10 μ M cWFW. The pore-forming 
helical peptide KLA-1 (0.3 μ M) served as positive control. The diagram depicts the average and standard error 
of two independent measurements. The statistical significances were calculated using unpaired (panels b/d) and 
paired (panel c) two-tailed Student t test. Strains used: (a/b) B. subtilis 168, (c) B. subtilis 168/DSM 402.
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Figure 3. cWFW reduces membrane fluidity in vivo and in vitro. (a) The fluidity of the cytoplasmic 
membrane was measured for B. subtilis cells upon 10 min incubation with increasing concentrations of cWFW 
using the fluidity-sensitive fluorescent dye laurdan. Please note that high laurdan generalised polarisation 
(GP) correlates with low membrane fluidity. The diagram depicts the average and standard deviation of three 
replicate measurements. (b) Time-resolved laurdan generalised polarisation (GP) was measured upon addition 
of 6 μ M cWFW. As a positive control, 50 mM of the membrane fluidiser benzyl alcohol (BA) was added to a 
replicate sample. The time point of addition is indicated with a dashed line. The graph depicts a representative 
measurement of three independent replicates. (c) Laurdan GP was measured for large unilamellar vesicles 
(LUVs) formed of E. coli polar lipid extract in the presence of increasing concentrations of cWFW. The 
peptide-to-lipid molar ratios (P/L) are indicated below the graph. See supplementary Figure S3b for examples 
of the recorded spectra. (d) Laurdan GP in the presence and absence of cWFW (P/L = 0.02) was measured for 
LUVs with varying lipid compositions (lipid molar ratios: PE/CL 87.5/12.5, PE/PG 75/25). See supplementary 
Figure 3c–f for recorded spectra. PE: palmitoyl-oleoyl-phosphatidylethanolamine, PG: palmitoyl-oleoyl-
phosphatidylglycerol, CL: cardiolipin and E. coli: E. coli polar lipid extract. (e) Average and standard deviation 
of cWFW-induced changes in laurdan GP (Δ GP) are shown for the different lipid compositions and peptide-to-
lipid molar ratios (P/L) from two independent experiments. The statistical significances were calculated using 
unpaired (panels a) and paired (panel e) two-tailed Student t test.
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Impact of cWFW-induced lipid domain formation on protein localisation. The massive 
cWFW-triggered phase separation of the cytoplasmic membrane is prone to influence the distribution of mem-
brane proteins. To analyse the general impact of cWFW on membrane protein localisation, we followed three 
dispersedly localised integral membrane proteins24. The chosen native proteins were YhaP, a Na+ efflux pump, 
and AtpA, a subunit of the F1Fo ATP synthase. The selection was supplemented with WALP23, an artificial model 
transmembrane helix27. For comparison, we investigated three dispersedly localised peripheral membrane pro-
teins which bind the membrane via an amphipathic helix. These proteins were the native sporulation protein 
SpoVM28 and two semi-synthetic proteins composed of GFP fused with the amphipathic helices of the cell divi-
sion protein SepF and the cell division placement protein MinD, respectively29. As shown in Fig. 5, all six tested 
membrane proteins were clearly delocalised upon cWFW treatment, thus demonstrating that the lipid domain 
formation indeed strongly affects membrane protein localisation (Fig. 5a). Surprisingly, whereas the integral 
membrane proteins were excluded from peptide-enriched domains, the analysed peripheral membrane proteins 
were accumulated in exactly these regions (Fig. 5b).
Taken together, the cWFW-triggered membrane phase-separation not only severely disrupts the overall 
membrane protein organisation, but also segregates membrane proteins into separate areas based on the type of 
membrane anchor utilised. This effect will inevitably cause major disturbances in membrane-associated cellular 
processes, and provides an explanation for the multitude of inhibitory effects observed in the proteome analysis.
Impact of protein delocalisation on inhibition of cell wall synthesis. Having identified the reduc-
tion of membrane fluidity and membrane phase separation as the mechanistic basis of the antimicrobial activity 
of cWFW, we further investigated how this leads to the observed rapid growth-inhibition of fully energised cells. 
B. subtilis grows by integrating two main processes: localised cell wall synthesis expanding the cell envelope and 
cell division separating the daughter cells. The proteome profile indicated that cWFW triggers a stress-response 
associated with inhibition of cell wall precursor lipid II biosynthesis, an essential process for both cell elongation 
and division. The observed inhibition of cell growth could therefore be caused by interference with cell wall 
synthesis. Two central membrane associated players in this process are the glycosyltransferase MurG, which 
catalyses the last step of lipid II synthesis30, and bacterial actin homologs of the MreB-type, which govern the 
correct cellular positioning of the lateral cell wall synthetic machinery31. In agreement with the stress response 
indicating disturbance in lipid II synthesis, cWFW triggered a release of both MurG and MreB-homologs from 
the membrane (Fig. 6a). To support this finding, we analysed whether the bacteria are able to synthesise lipid 
II in the presence of cWFW by staining the cells with a fluorescent derivative of the lipid II-binding antibiotic 
vancomycin (FL-Van). In B. subtilis, a high carboxypeptidase activity of PBP5 removes the vancomycin target 
D-Ala-D-Ala from matured cell wall. As a consequence, FL-Van binding is directly associated with lipid II and 
newly synthetised cell wall32. Indeed, a strong decrease of FL-Van staining was observed in cWFW-treated cells 
indicating significantly reduced amounts of lipid II (Fig. 6b). Together these findings provide strong evidence that 
cell wall synthesis is efficiently inhibited by cWFW.
Lipid domain formation triggers cell wall autolysis. Addition of elevated concentrations of cWFW not 
only inhibits growth but also induces cell lysis (Supplementary Figure 1, Supplementary Movie 1). This seemingly 
contradicts our results showing that the membrane integrity is not significantly compromised. There is, however, 
another possibility to explain the observed lysis. In growing cells the cell wall sacculus needs to expand by incor-
poration of new cell wall material. This process requires a finely tuned balance between cell wall synthesis and 
degradation of the existing cell wall by autolytic enzymes while continuously maintaining the crucial function as a 
support for turgor pressure33. Upon disturbance of the cell wall synthesis, the cytoplasmic membrane can become 
insufficiently supported against the large pressure difference between the interior and the exterior of the cell. The 
resulting cell lysis is classically observed with antibiotics which, unlike cWFW, directly target the cell wall syn-
thetic machinery34. However, the MreB-cytoskeleton is also involved in the regulation of autolytic enzyme activ-
ities35. The release of MreB and Mbl from the membrane could thus disturb the essential tight control of these 
potentially destructive cell wall degrading enzymes. To test this hypothesis, we analysed the bacteriolytic activity 
of cWFW in the absence of major autolysins LytCDEF. Indeed, the lysis triggered by cWFW was fully abolished 
in this strain background although the cells were still efficiently growth-inhibited (Fig. 6c). These results confirm 
that the lytic activity of cWFW is not due to disintegration of the cell membrane. Rather, cWFW causes weaken-
ing of the cell wall sacculus mediated by the cells’ own autolytic enzymes. The bacteriolytic property of cWFW is 
thus a consequence of triggered autolysis.
Discussion
In this study, we have analysed the mode of action of the small cyclic antimicrobial membrane-targeting peptide 
cWFW. We provide evidence that cWFW exhibits a complex mode of action which encompasses both the cyto-
plasmic membrane and the cell wall of B. subtilis. Upon integration into the membrane cWFW triggers a rapid 
reduction of membrane fluidity followed by lipid phase separation process. This domain formation not only 
disturbs the lipid matrix, but also causes a striking segregation of integral and peripheral membrane proteins 
into different membrane areas. Changes in the physical state and the composition of the immediate surrounding 
lipid bilayer can have a profound effect on membrane protein structure and function36–38. As a consequence, 
the cWFW-induced domain formation can both physically separate proteins which require close proximity for 
interaction or which catalyse successive steps in a biosynthetic pathway, and impair protein functionality due to 
conformational changes. The combined disturbances in membrane fluidity and protein localisation explain the 
broad cellular response to cWFW observed in the proteome analysis. In addition to causing general disarray of 
membrane-associated processes, cWFW inhibits cell wall synthesis by dissociating the actin homologs MreB 
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and Mbl, and the lipid II synthesis protein MurG from the cytoplasmic membrane. In agreement with cell wall 
disturbance, the cell lysis triggered by cWFW is a consequence of misregulation of cell wall autolytic enzymes 
rather than membrane disruption. Therefore, the antibacterial mode of action of this small cyclic cationic peptide 
is a combination of strong interference with general membrane organisation accompanied by an inhibition of cell 
wall synthesis and triggered autolysis.
Cationic antimicrobial peptides are generally assumed to kill bacteria by interfering with the integrity of the 
cytoplasmic membrane thereby causing leakage of the cytoplasmic content and cell de-energisation39. Based on 
investigations on model membrane systems, diverse modes of peptide-triggered membrane permeabilization 
have been suggested ranging from the formation of discrete pores and detergent-like activity to more subtle 
mechanisms such as perturbation of lipid packing39–41. The ability to trigger membrane rigidification combined 
with lipid domain formation, rather than membrane permeabilization or depolarisation, clearly distinguishes 
cWFW from other cationic AMPs. Hence, the case of cWFW demonstrates that cell permeabilization and 
de-energisation are not the only mechanisms by which membrane targeting AMPs can elicit strong bactericidal 
activities. The observed cross-interference with the cell wall synthetic machinery is, however, not unique for 
cWFW. In fact, most membrane-targeting AMPs induce cellular stress responses linked to inhibition of cell wall 
synthesis42,43. Based on work carried out with human β -defensin 3, Sahl and co-workers postulated a central role 
for lipid II and its biosynthesis pathway in the inhibition of cell wall synthesis by antimicrobial peptides42,44. Later, 
the linear cationic peptide MP169 was shown to trigger membrane dissociation of lipid II synthesis protein MurG 
as part of its complex mode of action13. Very recently, daptomycin was shown to target the cell wall synthesis by 
a more specific mechanism which includes intercalation into lipid microdomains associated with the cell wall 
synthetic machinery22. The ability of the fluidity-reducing cWFW to efficiently inhibit cell wall synthesis adds 
to the mounting evidence that membrane-associated steps of cell wall precursor biosynthesis are extraordinarily 
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Figure 4. cWFW triggers large-scale lipid domain formation in vivo. (a) Phase contrast and fluorescence 
images of B. subtilis cells stained with fluorescent membrane dye nile red before addition (upper panels) and 
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(middle panel) upon 20 min incubation. The right panel depicts a colour overlay of the images shown in left and 
middle panels. (d) Phase contrast and fluorescence images of B. subtilis cells stained with fluorescent membrane 
dye nile red after 20 min incubation with cWFW (12 μ M). Depicted are wild type cells (left panels), cells deficient 
for phosphatidylethanolamine (-PE, middle panels), and cells deficient for cardiolipin (-CL, right panels).  
(e) Fluorescence images of B. subtilis cell stained with laurdan upon 20 min incubation with cWFW (12 μ M). 
Depicted is the laurdan emission at 450 nm (left panel), 520 nm (middle panel) and a colour-coded laurdan 
GP map calculated from the images shown in left and middle panels, respectively. Strains used: (a–e) B. subtilis 
168 (wild type), (d) B. subtilis HB5343 (Δ psd, PE-deficient) and B. subtilis SDB206 (Δ clsA, Δ clsB, Δ ywiE, CL-
deficient).
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incubation with 12 μ M). (b) Comparable images are depicted for cells expressing different peripheral membrane 
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sensitive to membrane disturbances. The dual impairment of both the cytoplasmic membrane and cell wall syn-
thesis therefore represents a cellular weak point which is frequently exploited by membrane targeting AMPs. It 
is tempting to speculate that this phenomenon contributes to the low incidence of resistant mutations emerging 
against cWFW (unpublished data), and in general against membrane targeting AMPs45.
In the context of lipid domains caused by AMPs, the discussion has focussed on the separation of anionic and 
zwitterionic lipids caused by preferential binding of cationic peptides to the negatively charged lipids40,46. The 
resulting phase boundary effects are considered the basis for the enhanced permeability of the lipid matrix47,48. 
In this manuscript, we provide direct microscopic in vivo evidence for peptide-induced formation of large lateral 
lipid domains in B. subtilis. Instead of demixing of anionic and zwitterionic lipids, however, the observed lipid 
domains display a difference in membrane fluidity. The cWFW-triggered domain formation is thus conceptu-
ally comparable to a phase-behaviour of lipid bilayers, and bears an intriguing similarity to cholesterol-induced 
membrane rigidification and lipid-raft formation49. The co-occurring segregation of membrane proteins adds 
a significant level of complexity to the phenomenon. Rather than being driven by a bona fide phase separation 
between fluid and less fluid lipid regions, the observed domain formation could also be caused by cWFW-induced 
changes in bilayer thickness, an effect frequently observed for antimicrobial peptides50. The segregation of inte-
gral membrane proteins away from the cWFW-enriched domains could be triggered by a hydrophobic mis-
match between the transmembrane domains and the peptide-enriched membrane areas. The membrane areas 
with low density of integral membrane proteins could, in turn, attract peripheral membrane proteins and lipid 
dyes due to the increased surface area available for binding. Substantial amount of future work, both in vivo and 
in vitro, is required to understand the detailed molecular characteristics of the cWFW-triggered lipid domains. 
Nevertheless, our findings confirm that lipid phase separation and related protein segregation into the separate 
membrane domains are the key events in the mode of action of the cyclic R-, W-rich hexapeptide cWFW.
In summary, the antimicrobial mechanism of this membrane-active, non-depolarising peptide is based on 
substantial disruption of the lipid and protein organisation of the cytoplasmic membrane which has severe con-
sequences for essential cellular processes as exemplified by the inhibition of cell wall synthesis. We consider the 
phenomenon a novel antimicrobial mode of action which provides valuable insight into the diverse mechanisms 
by which membrane-active peptides unfold their antimicrobial potential.
Methods
Peptide synthesis. As reported previously, the parent peptide cWFW was prepared by multiple sol-
id-phase synthesis using an Fmoc/tBu strategy according to SHEPPARD51–53. Peptide purification and analysis 
were accomplished with high performance liquid chromatography (HPLC) on a Jasco LC-2000Plus (Japan) and 
Dionex UltiMate 3000 with ProntoSil 300–5-C18-H columns (250 × 4.6 mm, 5 μ m) (Bischoff Chromatography, 
USA). Peptide mass was determined by UPLC-MS (ultra-performance liquid chromatography mass spectrome-
try) on an ACQUITY UPLC® System (Waters) using an Ascentis® Express Peptide ES-C18 column (3 × 2.1 mm, 
2.7 μ m) (Sigma-Aldrich). Final peptide purity was determined to be > 95%. The labelled peptide derivative 
(FL-cWFW) containing 3-N-(7-nitrobenz-2-oxa-1,3-diazole-4-yl)-2,3-diamino-propionic acid (Dap-NBD) was 
purchased from Biosyntan GmbH, Berlin.
Bacterial strains and growth conditions. Cells were inoculated from an overnight culture 1:100 and 
grown to mid-log phase (OD600 = 0.2–0.4). Unless stated otherwise, all experiments were carried out in LB 
medium at 37 °C. Cell numbers were determined using a Petroff-Hausser counting chamber: OD600 = 1 corre-
sponds to 8.8 × 107 CFU/ml B. subtilis. Further information on strains, conditions of gene induction, and minimal 
inhibitory concentration are listed in Supplementary Table 4.
Construction of strains. For the construction of a B. subtilis strain expressing WALP23-GFP, the synthetic 
sequence encoding WALP2354 was constructed by annealing oligonucleotides WALP23-for and WALP23-rev, 
followed by PCR-filling the single-stranded regions. The resulting DNA-fragment was amplified using oligonu-
cleotides WALP23-IFfor and WALP23-IFrev, and fused with plasmid pSG115455 PCR-linearised with oligonu-
cleotides pSG1154-for and pSG154-rev using In-Fusion Cloning (Clontech). The final plasmid was integrated 
into amyE-locus of B. subtilis resulting in strain HS64. For the construction of a B. subtilis strain expressing 
GFP fused with JunLZ-dimerisation domain56 and a membrane-targeting sequence (MTS) of B. subtilis MinD57, 
junLZ-MinDMTS was PCR-amplified from a previously constructed E. coli plasmid pHJS10057 using oligonu-
cleotides JunLZ-for and MTS-rev, followed by ligation into BamHI/HindIII-linearised E. coli-B. subtilis shuttle 
vector pSG172955. At last, the plasmid was integrated into amyE-locus of B. subtilis resulting in strain HS65. 
Transformation of B. subtilis 168 with either plasmid DNA or chromosomal DNA from donor strains was carried 
out as described in Hamoen et al.58. See Supplementary Table 5 for oligonucleotide sequences.
Antimicrobial activity. The minimal inhibitory concentration (MIC), which is defined as the lowest con-
centration able to inhibit growth of a microorganism in vitro59, was analysed as described before60. Briefly, bacte-
ria were grown to mid-log phase and diluted in growth medium to give a final cell number of 5 × 105 cells/well in 
96 well microtiter plates. A microdilution technique was applied where small volumes of peptide solutions were 
added in a serial dilution ranging from 100 to 0.05 μ M. Cells were cultivated for 18 hours, 37 °C, 180 rpm, followed 
by photometrical detection of the optical density using a microplate reader (Tecan). Peptide concentrations were 
tested in triplicates in three independent experiments.
Proteome analysis. B. subtilis 168/DSM402 was grown in chemically defined Belitzky minimal medium 
(BMM)61. Cultures were incubated at 37 °C under steady agitation. Minimal inhibitory concentrations (MIC) 
were determined as described previously62. In growth experiments, exponentially growing cultures were exposed 
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to a concentration range of peptide (Supplementary Figure 1)62. For physiological stress experiments, concentra-
tions were chosen that led to 50% reduction of the growth rate. For proteomic profiling, as well as for all follow up 
experiments performed under the same growth conditions, 8 μ M cWFW were used.
Radioactive labelling of newly synthesised proteins and subsequent separation of the cytosolic proteome 
by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) was performed as previously described62. 
Analytical gel images were analysed as described by Raatschen & Bandow63 using Decodon Delta 2D 4.1 image 
analysis software. Proteins more than two-fold upregulated in three independent biological replicates were 
defined as marker proteins. Protein spots were identified by MALDI-ToF/ToF or nanoUPLC-ESI-MS/MS using 
a Synapt G2-S HDMS mass spectrometer equipped with a lock spray source for electrospray ionisation and a ToF 
detector (Waters) as previously reported (Supplementary Tables 2 and 3)62.
Membrane potential measurement. Peptide-induced changes in membrane potential were measured 
using the voltage-sensitive fluorescent dye DiSC3(5). In aqueous solution DiSC3(5) emits strong fluorescence 
which is quenched upon accumulation in polarised cells. Upon depolarisation, DiSC3(5) is released from the 
cell resulting in an increased fluorescence due to de-quenching. B. subtilis 168 was grown at 37 °C to mid-log 
phase and diluted in LB medium to OD600 0.2. After centrifugation for 1 min at 16,500 rpm, the supernatant was 
removed and cells carefully resuspended in 1 ml fresh pre-warmed LB containing 0.1 mg/ml BSA. Subsequently, 
140 μ l aliquots of the cell suspension were transferred into a 96 well microtiter plate and allowed to settle. 10 μ l of 
15 μ M DiSC3(5) in LB/15% DMSO were added to the wells to give a final DiSC3(5) concentration of 1 μ M. Cellular 
accumulation (quenching) of DiSC3(5) was monitored until the signal had reached stable fluorescence levels. The 
peptides were added at desired concentrations at 5 μ l/well, and the resulting changes in DiSC3(5) fluorescence 
were analysed for at least 20 min using a Fluostar Optima, BMG Labtech. Solutions, plates and instruments were 
warmed to 37 °C prior to use.
ATP measurement. For the determination of cellular ATP levels samples were incubated with increasing 
concentration of cWFW for 20 min, followed by flash-freeze in liquid N2 in order to stop metabolism. Cell lysis 
and measurement of cell ATP levels were carried out using ATP bioluminescence Assay Kit HSII (Roche Applied 
Science) following manufacturer’s instructions using a BMG Fluostar Optima luminometer. The measured lumi-
nescence was calibrated with a serial dilution of ATP and triplicate samples were equalised against the optical 
density of the corresponding cell suspensions.
Ion analysis. Only metal-free plastic ware and ultrapure water (Bernd Kraft) were used. All centrifugation 
steps were reduced to 2 min to reduce sample handling time. Cultures were adjusted to OD500 = 0.4 prior to anti-
biotic exposure to ensure equal cell count in each sample. Samples were prepared as described by Wenzel et al.13. 
Briefly, B. subtilis 168/DSM402 was grown in BMM until early exponential growth phase. For determination of 
ion concentrations, subcultures were incubated with 8 μ M cWFW for 15 min, followed by cell harvest by centrif-
ugation, washed twice in TE buffer (100 mM Tris-HCl, 1 mM EDTA, pH 7.5) and once in the same buffer without 
EDTA. The obtained cell pellets were digested in 65% nitric acid (Bernd Kraft) at 80 °C for 16 h. Prior to element 
analysis, samples were diluted with ultrapure water to a final nitric acid concentration of 10%. Element concen-
trations were determined by inductively-coupled plasma atomic emission spectroscopy using an iCAP* 6300 Duo 
View ICP Spectrometer (Thermo Fisher Scientific) as described before13. Liquid calibration standards ranging 
from 10 μ g/l to 10 mg/l of each element of interest (Fe, K, Mg, Mn, Na, S, P and Zn) (Bernd Kraft) were run before 
each series of measurements and selected standards were additionally run every 20 samples as quality control. 
Sulfur and phosphorus served as additional internal controls for cell mass. Element concentrations were con-
verted into intracellular ion concentrations based on the B. subtilis cellular volume, which was taken as 3 × 10–9 μ l 
based on average rod size determined by cryo-electron microscopy images by Matias and Beveridge64,65.
Membrane conductivity measurements. Free-standing planar lipid membranes were formed accord-
ing to an established protocol66 from a 20 mg/mL solution of E. coli lipid (Avanti Polar Lipids, Alabaster, USA) 
in n-decane and spread across a circular aperture (Ø 150 μ m) in a polysulfone bilayer cup between two aqueous 
phases in a bilayer chamber (both Warner Instruments, LLC, Hamden, USA). Transmembrane current was meas-
ured with Ag/AgCl electrodes and an Axon GeneClamp 500 amplifier (Molecular Devices, Sunnyvale, USA) 
under voltage-clamp conditions. A 4-pole Bessel with a 3-dB corner frequency of 500 Hz was used as record-
ing filter. The amplified signal was digitised by a PCI 6025E computer board (National Instruments, Munich, 
Germany) and analysed with WinEDR (Strathclyde Electrophysiology Software, Strathclyde, UK). Membrane 
conductivity was calculated for zero-voltage from voltage-current dependencies of the steady-state current 
(recorded by application of ramp voltage from − 100 to 100 mV). Peptides were added at both sides of the mem-
brane (cWFW: 10 μ M, KLA-1: 0.3 μ M; buffer: 10 mM HEPES, 150 mM KCl, pH 7.4, 21–23 °C). Gaussian filters of 
3–11 Hz were applied to reduce noise while data processing.
Membrane fluidity measurements. Membrane fluidity was investigated with the small hydrophobic flu-
orescent dye laurdan, which integrates into cellular membranes and detects changes related to the lipid packing 
of the surrounding bilayer67,68. The resulting changes in the fluorescence emission spectrum can be detected 
either spectroscopically or with fluorescence microscopy. A mathematical quantification of the emission shift is 
achieved by calculation of the laurdan GP (generalised polarisation) with GP = (I435 − I490)⁄(I435 + I490).
B. subtilis 168 cells were grown to OD600 ~ 0.5 in LB/0.1% glucose and incubated with 10 μ M laurdan for 5 min, 
shaking in the dark. Subsequently, cells were washed 4 times in PBS/0.1% glucose, and 150 μ l aliquots were trans-
ferred to a 96 well microtiter plate. The peptide was added at the desired final concentration at a maximum 
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volume of 3 μ l/well. The supernatant removed from the cells after the last washing step served as background 
for laurdan fluorescence not associated with cells. The solvent benzyl alcohol (BA) has a fluidising effect on lipid 
bilayers and was used as positive control (50 mM). All samples were shaken briefly before fluorescence detec-
tion at 435 ± 5 nm and 490 ± 5 nm (upon excitation at 350 ± 10 nm) on a plate reader (Fluostar Optima, BMG 
Labtech). Laurdan fluorescence was monitored for at least 20 min. Peptide influence on membrane fluidity was 
investigated in three independent experiments. Laurdan fluorescence in liposomes was recorded using an LS 50B 
spectrofluorometer (Perkin-Elmer Corp., Germany). Samples of 0.25 mM LUV suspension were continuously 
stirred during the experiment and temperature control was achieved by a built-in Peltier element. Laurdan flu-
orescence was detected separately at 435 and 500 nm, respectively. The average of three measurements for each 
preparation was calculated to determine corresponding laurdan GP values. See Scheinpflug et al.69 for detailed 
protocols and discussion of the laurdan-based fluidity measurements.
Liposome preparation. For in vitro analysis of membrane fluidity 1-palmitoyl-2-oleoyl-sn-glycero-3
-phosphoethanolamine (POPE), cardiolipin (CL, bovine brain), 1-palmitoyl-2-oleoyl-sn-glycero-
3[phosphor-rac-(1-glycerol)] (POPG) and natural E. coli polar lipid extract were purchased from Avanti® Polar 
Lipids (Alabama, USA). Lipid powders were dissolved in chloroform/methanol (3/1) and individual compo-
nents of binary mixtures were mixed in desired combinations: POPE/CL 87.5/12.5, POPE/PG 75/25. E. coli lipid 
extract was used as obtained. 0.2 mg/ml laurdan solution in chloroform was added to each lipid mixture giving a 
laurdan-to-lipid molar ratio of 1.5:1000. Large unilamellar vesicles (LUVs) were prepared using a standard pro-
tocol5 by extrusion of lipid solution in phosphate buffer through two stacked polycarbonate filters (100 nm pore 
size) using a MiniExtruder (Avestin Europe, Germany). Vesicle size was ~110 nm, as determined by dynamic light 
scattering performed on a Zetasizer Nano ZS ZEN 3600 device (Malvern Instruments, UK). Aliquots were stored 
at − 20 °C under argon atmosphere for replicate experiments. 1 mM lipid stock solutions were used for plain 
vesicles, while peptide-containing LUVs were prepared from 2 mM lipid stocks mixed with an equal volume of 
cWFW in phosphate buffer. Peptide concentration varied from 10 to 50 μ M, corresponding to molar peptide-lipid 
ratios of P/L = 0.01 to 0.05. To obtain homogeneous peptide distribution the suspensions were vigorously vor-
texed and subjected to 1–2 cycles (5 min/cycle) in an ultrasonic bath. Vesicles were further extruded as described 
above. LUV size was 110–130 nm, depending on peptide-lipid molar ratio.
Fluorescence microscopy. Peptide-induced formation of lipid domains was visualized with the membrane 
dye nile red. The fluorescence of the dye is very low in polar solvents but strongly increases in hydrophobic envi-
ronments. Nile red intensity is considered to be independent of the interaction with certain lipid head groups but 
is affected by the degree of membrane fluidity25. Cells were grown to mid-log phase, adjusted to OD 0.2 in growth 
medium and incubated with 12 μ M peptide for 20 min, shaking. Microscope slides were covered with a thin layer 
of H2O/1.2% agarose and transferred to 8 °C for polymerisation (adjusted to room temperature prior to use). Nile 
red (final concentration of 1 μ g/ml) was added to the cells immediately before imaging. Fluorescence microscopy 
was performed using Nikon Eclipse Ti (Nikon Plan Fluor 100x/1.30 oil ph3 DLL objective).
Peptide-induced protein delocalisation was investigated with B. subtilis strains expressing fluorescent 
fusion-proteins (see supplementary Table 4). For this aim, the cells were cultivated at 37 °C to early/mid-log 
phase, adjusted to OD600 of 0.2 in growth medium, and incubated with 12 μ M cWFW for 20 min at 37 °C under 
shaking. Defects in cell wall synthesis were analysed after 15 min pre-incubation of B. subtilis wild type cells 
with 12 μ M cWFW followed by addition of 0.5 μ g/ml BODIPY-labelled vancomycin (FL-Van, Thermo Fisher 
Scientific) mixed with an equal concentration of unlabelled vancomycin for 5 min. Fluorescence imaging was 
performed as described above. All microscopy experiments were carried in biological triplicates.
Fatty acid analysis. The fatty acid composition of B. subtilis membranes was determined for cells grown at 
37 °C in LB medium and for cells challenged with cWFW. Cell samples were withdrawn at comparable optical 
densities and upon re-initiation of growth of the cWFW-stressed cells in order to provide sufficient time for 
adaptation. The analysis was performed by conversion of lipids into fatty acid methyl esters (FAME) followed 
by gas chromatography. The analysis was carried out by the Identification Service of the DSMZ, Braunschweig, 
Germany.
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